Term
Non SteroidalAnti-Inflammatory drugs (NSAIDs)/ Non-Opoid Analgesics MOA |
|
Definition
All NSAIDs, incl acetimanophen, inhibit prostaglandin synthesis via inhibition of the prostaglandin synthetase family of enzymes, specifically inhibiting cycloxygenase (COX), to one degree or another.
- All NSAIDs, except acetaminophen are anit-inflammatory
|
|
|
Term
|
Definition
as analgesic- HA, muscle ache, joint pain,
anti-pyretic,
anti-inflammatory
treat inflamm. cond. e.g arthritis,
ASA inhibits platelet aggregation |
|
|
Term
Acetaminophen (APAP) (N-acetl-parap-aminophenol) *paracetamol * (phenacetin metabolized to APAP) |
|
Definition
non- opiate analgesic with NO anti-inflammatory effects. |
|
|
Term
Method of Action of salicylates |
|
Definition
Inhibits prostaglandin synthesis by inhibiting cyclooxygenase. Prostaglandins normally cause hyperalgesia: make pain receptors more sensitive to other pain mediators (i.e. serotonin, substance P, bradykining)
Increase response to painful stimili, so reduce PGs will decrease response.
Inhibiting prostaglandin synthesis with both peripheral and central actions. |
|
|
Term
what role do prostaglandines play in antipyretic effect of NSAIDs? |
|
Definition
- PGs in hypothalamus increase body temperature via an increase in cAMP.
- ASA has a central effect to inhibit prostaglandins in hypothalamus thus decr. high body temperature by increased vasodilation and sweating.
- ASA has no effect on normal temperature.
|
|
|
Term
- what role does prostaglindin play in the anti-inflammatory effect of ASA?
|
|
Definition
Relates to peripheral inhibition of cyclo-oxygenase enzyme.
Cell damage tiggers inflammation which releases PGs and others
PGs may sensitize receptors to other inflammatory mediators: 5-HT, bradykining, histamine.
- Inhibit PG synthesis effective to relieve inflamation.
- note that phagocytes migrate into area and cause lysozomal enzymes to be released with subsequent lysozomal enzymes and tissue damage that increases inflammation. But prostaglanding inhibitors do not block this.
|
|
|
Term
what role does prostaglindin play in the platelet aggregation effect of ASA? |
|
Definition
ASA is most effective because irreversible acetylation of the cyclooxygenase enzyme, thus inhibits synthesis. PGs (thromboxane A2) are involved in stimulating platelet aggregation.
proven useful in decreasing risk in thrombolytic diseases |
|
|
Term
what role does prostaglindin play in the gastrointestinal effect of ASA & NSAIDs? |
|
Definition
- salicylates and all NSAIDs cause GIT disturbances because harm stomach's ability to protect itself.
- Ulceration, bleeding, anemia & perforation may result.
- A prostaglandin may be protective in stomach- stimulates mucous and bicarb secretion, inhibit H+ secretion and cause vasodilation.
|
|
|
Term
effect of ASA and NSAIDs on respiration |
|
Definition
high doses increase respiration, deep rapid rate blows off all our CO2 leads to respiratory alkalosis (elevated blood pH). |
|
|
Term
what are the uses of aspirin? |
|
Definition
mild to moderate pain relief. |
|
|
Term
is aspirin selective or non-selective? |
|
Definition
non-selctive inhibitor of cyclooxygenase (inhibit COX1 and COX 2 very well) |
|
|
Term
what are the metabolic effects of NSAIDs? |
|
Definition
aspirin/ acetysalicylic acid if really high dose will uncouple oxidative phosphorylation[the link b/w respiratory activity and storage of energy as ATP --> leads to fever, inreased O2 consumption, increased heat production] in overdose and especially in children |
|
|
Term
pharmokinietics of aspirin |
|
Definition
ASA hydrolyzes to salicylic acid (still active, 1/2 life 6-30hrs) but once deacytelated can no longer irreversibly bind to cyclooxygenase.
ASA ( 1/2 life 30mins).
so increased dose of ASA, means more salicylic acid (metabolized in liver mainly), means slower elimination -> increased concen. and increased toxicities |
|
|
Term
|
Definition
GIT: upset, nausea, vomiting, ulceration, bleeding (anemia)
- Serious overdose (esp children: note methyl salicylate/winter green oil used in baking and candy making can be toxic to kids.)
- Hypersensitivity: anaphlylaxis (cross reactive to other NSAIDs), 25% are sensitive to aspirin with no immunologic reaction. Small percetn of pts are actually allergic to aspiring: sensitized lymphocytes.
- Intoxication: Low dose = tinnitus, dizziness, HA, confusion
- Intoxication: higger doses "salicylism"= nausea, vomitting, diarrhea, hypernea, acid/base problems, hemorrhage Tx: supportive.
- Reye's syndrome: oif kids <15 get aspirin after flu/chicken pox/ viral dsease causes nerve damage and liver problems. yes give kids acetaminophen.
- (aspirin increases uric acid levels in body, inhibits the transport mechanisms (similar to thiazides and loop diruetics)
|
|
|
Term
|
Definition
analgesic, anti-pyretic anti-inflammatory |
|
|
Term
overdose in aspirin can cause |
|
Definition
fever, diarrhea, hypernea, acid/base problems, hemorrhage, can kill you (lethal dose = 20g) |
|
|
Term
Method of action of Acetaminophen (APAP) |
|
Definition
inhibits COX enzyme but does NOT work well in periphery.
[ other non-opiate analgesics inhibit COX 1 and COX2 enzyme ]
|
|
|
Term
Acetaminophen (APAP) USES |
|
Definition
good analgesia
fever reduction,
NO anti-inflammatory
No platelet inhibtion
NO increase in uric acid
No risk of Reye's syndrome (can use in chilren)
Problem in pts with GOUT
less water retention.
|
|
|
Term
Acetaminophen (APAP) OVERDOSE Toxicities |
|
Definition
OVERDODE mainly:
APAP metabolized to toxic oxygen intermediate by p450 in the liver and the kidney; if not neuralized by gluthatione then:
hepatic necrosis
Renal necrosis
Hypoglycemia
Coma
Death
Fatal dose = 25g (all the gluthatione used up) |
|
|
Term
Acetaminophen Toxicities:
Early Symptoms of Overdose w/in 24 hrs |
|
Definition
Muld nausea, vomiting, anorexia, pain
Can treat early overdose with N-ACETYL CYSTEINE (antidote in first 10 hours to increase conjuction of toxic metabolite.
- Alcohol depletes glutatione; potentiates effects.
|
|
|
Term
Acetaminophen Toxicities:
2 to 6 days after Overdose w/in 24 hrs |
|
Definition
acetaminophen metabolized to highly reactive intermediates then: hepatic damage, liver failure,
bleeding,
jaundice, death |
|
|
Term
NON-opiate analgesic NSAIDs uses |
|
Definition
analgesic, antipyretics, anti-inflammatory.
treate Rheumatoid arthritis,
chronic inflammatory diseases..
All INHIBIT PROSTAGLANDIN SYNTHESIS (INHIBIT COX enzyme) |
|
|
Term
|
Definition
leukotriene, hetes and other inflammatory mediators made INSTEAD of prostaglandins.
pt can be cross senstive to NSAIDs (inhibit COX enzymes) and aspirin.
|
|
|
Term
Can pt taking acetaminopen(APAP) be cross-sensitive to aspirin? |
|
Definition
no because APAP does not cause peripheral effects |
|
|
Term
|
Definition
10=25% of pts that have one of the following will have aspirin sensitivity: 1. Asthma
2. Nasal Polyps,
3. Chronic uticaria.
- only 1% of poupulation have aspirin sensitivity or "aspirin tolerance"
|
|
|
Term
Chronic use of NSAIDS can cause |
|
Definition
- Fluid accummulation due to effects on kidney fct.
- increased risk of gastric problems
|
|
|
Term
NSAIDs has what ocular toxicities? |
|
Definition
Sudden blur of vision,
diffuse corneal stroma deposits,
EOM abnormalities,
color vision disturbances,
toxic amblyopia. |
|
|
Term
other NSAIDs, other than APAP & ASA |
|
Definition
Indomethacin (Indocin)
Sulindac (clinoril)
Ibuprofen (motrin) (Advil)
Naproxen (Naprosyn, Anaprox) (Aleve)
Diclofenac (Voltaren) |
|
|
Term
|
Definition
last resort NSAID drug
10-40X apirin potenscy, high tocicities
Common Toxicitiy: GIT & HA, same ocular toxicities.
Rx only |
|
|
Term
|
Definition
has an active metabolite: more effective,
- less GI tox than indomethacin,
- Good for eldery px
Rx Only |
|
|
Term
Ibuprofen (motrin, advil) |
|
Definition
More potent than aspirin,
cause less GI toxicities,
OVER THE COUNTER. |
|
|
Term
Naproxen (Naprosyn, Anaprox) *Aleve |
|
Definition
longer duration of action.
subjectively better
OTC |
|
|
Term
|
Definition
NSAID that decreases free arachidonic acid that results when this NSAID inhibits COX in tissues. Arachidonic acid is taken up into the cell membrane.
Used for topical ocular pain due to laser treatments |
|
|
Term
|
Definition
Selective COX-2 inhibtor= used as antI-inflamm, analgesic and antipyretic.
Little action on GI tract and platelet aggregation (COX-1 mediated effect).
good for pt sensitive to GI effects of other NSAIDS |
|
|
Term
Celecoxib (celebrex) Toxicities? |
|
Definition
kidney problems,
contraidicated in pt with aspirin sensitivity and sulfa allergies |
|
|
Term
Contraindications for ALL NSAIDs
|
|
Definition
Known Allergic Hypersensitivy,
NSAID induced asthma or utricarial
Asprin triad: asthma, nasal polyps, urticaria.
Pregnancy: (need prostaglanding production for foramen ovale in infant heart to close before birth.
Coronary Artery bypass grafting surgery- cos increased bleeding |
|
|
Term
|
Definition
physiologic role in glucose, aminoacid & protein metabolism and use,
Made by beta cels of pancreatic islets of langerlans: make pro-insulin
Activate the uptake of glucose from blood plasma so we can use the energy from the glucose in our cells. |
|
|
Term
|
Definition
Insulin receptors at cell membrane, linked to tyrosine kinase, once activated leads to phosphorylation of tyrosine and activation of GTP binding proteins.
cascade to stimulate transcription factor to increase glucose metabolism proteins, increase of glucose uptake molecules, increase of molecules that take glucose and convert it to glycogen |
|
|
Term
|
Definition
Lack/ Apparent lack of insulin |
|
|
Term
Type 1- diabetes mellitus (IDDM) |
|
Definition
Absolute lack of insulin, insulin dependent DM:
no beta cell production,
- Treat w/ insulin to survive
Onset: in childhood, unrelated to diet and exercise. |
|
|
Term
Type 2- diabetes mellitus |
|
Definition
- Apparent lack of insulin OR decreased insulin senstivity,
- Have insulin but receptors are less sensitive to insulin,
treat w/ oral agents (or insulin)
Assoc: obesity and diet high in sugar, reduce or eliminate need for drugs with diet and exercise.
|
|
|
Term
|
Definition
- Human insulin (recombinant DNA dervided, injection only)
- regular insulin (crystalline zinc or lispro) (humilin)
- Isophane insulin suspenstion (NPH) (Humulin N or Novolin N)
- Insulin glargine (lanthus)
- Combo can allow better control
|
|
|
Term
regular insulin (crystalline zinc or lispro) (Humlin or humilog) |
|
Definition
5-7hrs
short acting like before meals; effects last throughout the day. |
|
|
Term
Isophane insulin suspension (NPH) (Humulin N or Novolin N) |
|
Definition
18-24 hrs
Intermediate acting |
|
|
Term
Insulin glargine (lanthus) |
|
Definition
|
|
Term
oral agents to control blood glucose; Type 2 DM |
|
Definition
oral agents may be sufficient enough if insulin is available ie. functional beta cells exist.
Problem: normally insulin stimulated by glucose and food ingestion so that glucose can be uptaked into tissues, but with type 2 DM, decreased insulin sensitivity adn asynchronous release of insulin, not released appropriately so longer duration of high glucose levels.
Goal: control glucose levels that damage vasculature leading to diabetic retinopathy, kidney damage & neuropathy |
|
|
Term
|
Definition
sulfonylureas & biguanides,
glucosidase inhibtiors,
glitazones* |
|
|
Term
Oral hypoglycemia Tx approach |
|
Definition
stimulates insulin release. |
|
|
Term
Antihyperglycemic (Antidiabetic) |
|
Definition
mimics other molecules that stimulate insulin release; decreases risk of hypoglycemia |
|
|
Term
MOA of Sulfonylureas (oral hypoglycemics) |
|
Definition
{More insulin released and more sensitive peripheral tissues}
stimulate the release of insulin from functional beta, by binding to an ATP-dependent K+ channel leading to decrease in K+ efflux, increase in Ca2+ influx, which gives greater insulin release upon stimulation by glucose.
- increased sensitivity of peripheral tissues to the actions of insulin
|
|
|
Term
Egs of Sulfonylureas which treat Type 2 DM, |
|
Definition
tolbumatide
glipizide,
glyburide,
glimepiride. |
|
|
Term
Toxicities of Sulfonyurea oral hypoglycemics |
|
Definition
Hypoglycemia (profound)
nausea
rash
blood disorders,
jaundice,
muscle weakness and ataxia,
dizziness and mental confusion. |
|
|
Term
secratogues; oral hypoglycemics |
|
Definition
E.g Reaglinide (prandin)
Nateglinide (stralix)
|
|
|
Term
MOA of secratogues; oral hypoglycemics |
|
Definition
- Same receptor sites and mechanism as sulfonyl ureas:
MOA: enter beta secretory cells,
bind to ATP-dep K+ channel,
decrease in K+ efflux & increase Ca2+ influx, increase in insulin secretion,
- increased sensitivity in peripheral tissues to insulin (includes glucose uptakes)
|
|
|
Term
Tocicities of oral hypoglycemics: Secretagogues (Repaglinide and Nateglinide) |
|
Definition
Hypoglycemia (less likely than sulfas)
Nausea &diarrhea
Dyspesia
NO cross allerigic hypersensitivity because these are not sulfa drugs.
short duration therefore immediately before meal |
|
|
Term
|
Definition
do NOT stumulate insulin release form beta cells,
much less likey to produce hypoglycemia. |
|
|
Term
MOA of metformin (glucophage),
belongs to biguanides; antihyperglycemics |
|
Definition
- decrease glucose output from liver (gluconeogenesis) which lowers glucose plasma levels.
- Increae insulin sensitivity on muscle & fat (due to lower glucose levels), glucose uptake into cells increased.
|
|
|
Term
MOA of Biguanides (metformin); Antihyperglycemics |
|
Definition
reduce glucose output
increase sensitivity on muscle and fat |
|
|
Term
Toxicities of Biguanides (metformin); Antihyperglycemics |
|
Definition
common: diarrhea, nausea, other GIT symptoms,
Rare: significant increase in lactice acidosis especially renal insufficient pt. can kill!,
megaloblastic anemia (rare) |
|
|
Term
MOA of Glucosidase inhibitors;
Antihyperglycemics |
|
Definition
Inhibit GIT enzymes that break down complex carbs (complex carbs must be broken down or absorbed)
eg. Acarbose(Procose)
Miglitol (Glyset) |
|
|
Term
Toxicities of Glucosidase inhibitors |
|
Definition
cause GIT disturbacnes. diarrhea,
pain, gas.
Acarbose (Glucobay) (precose),
Miglitol (Glyset) |
|
|
Term
what do the antihyperlipidemics Thiazolidinediones (glitazones) do? |
|
Definition
anti hyperglycemic agents that increase sensitivity of insulin receptors.
|
|
|
Term
MOA of antihyperlipidemics Thiazolidinediones (glitazones) |
|
Definition
- act as agonists to PPAR (peroxisome proliferator-activated receptor) to increase gene transcription for "glucose uptake and utilization" proteins.
Increase in glut-4 (transporter for glucose), lipoprotein lipase, fatty acid transporter protein etc |
|
|
Term
Toxicities of of antihyperlipidemics Thiazolidinediones (glitazones) |
|
Definition
Rosiglitazones (Avandia)
Pioglitazones (Actos)
- weight gain & fluid retention
- significat: hepatoxicity & congestive heart failure,
|
|
|
Term
MOA of AntiHyperglycemic Agent
Liraglutide (Victoza)
Exenatide (byetta) |
|
Definition
Liraglutide (Victoza)
Exenatide (Byetta)
MOA: a GLP-1 receptor agonist
MOA: mimics physiologic hormone glucagon -like peptide (GLP-1) to:
- inhibit glucagon secretion,
- increase insulin secretion.
- delays gastric emptying.
- Close to normal physiologic response to a meal ingestion.
|
|
|
Term
Toxicities of AntiHyperglycemic Agent
Liraglutide (Victoza) |
|
Definition
Common: NVD
More serious & less frequent: pancreatitis
Possible thyroid carcinomaa |
|
|
Term
Toxicities of antihyperlipidemic: Exenatide (byetta) |
|
Definition
Common: NVD
More serious,less frequent: pancreatitis
anaphylactic reactions
|
|
|
Term
MOA of Antihyperglycemics
Sitagliptin (Januvia)
Saxagliptin (onglyza)
Linagliptin (Tradjenta) which are DPP-4 inhibitors |
|
Definition
MOA: These dipeptidyl-peptidase 4 (DPP-4) inhibitors blocks the endogenous breakdown of GLP-1. thus increasing the duration of incretin action to stimulate insulin release and inhibit glucagon release.
(Incretin includes GLP-1 and others)
-orally effective!!! |
|
|
Term
Toxities of Antihyperglycemia
Sitagliptin (Januvia)
Saxagliptin (onglyza)
Linagliptin (Tradjenta) |
|
Definition
|
|
Term
which of the following DM 2 antihyperlipidemic drugs are orally effective? pick 3
a) Sitagliptin (januvia)
b) Saxagliptin (Onglyza)
c)Linagliptin (Tradjenta)
d)Liraglutide,
e) Exenatide |
|
Definition
Sitagliptin (januvia)
Saxagliptin (Onglyza)
Linagliptin (Tradjenta) |
|
|
Term
Toxicities of Antihyperglycemics: Sitagliptin (januvia)
Saxagliptin (Onglyza)
Linagliptin (Tradjenta) |
|
Definition
Common: upper respirator infxn (like a cold)
Nasopharyngytis
Headache
More serious: pancreatitis, hypersenstitivity reactions |
|
|
Term
MOA of Inhibitors of type 2 sodium-glucose transporter (SGLT2) system.
|
|
Definition
MOA: inhibit SGLT2 in kidney.
Normal= glucose in filtrate reabsorbed.
Abnormal DM: too much glucose, not all rebasorbed so Polyuria.
Inhibitors of SGLT2 system prevent reabsoprtion of glucoes from the kidney, thus allowing bllood glucose levels to be low.
These are good for any pt. to lower blood glucose. |
|
|